GASTROINTESTINAL SUBMUCOSAL TUMOUR

This adverse event was reported 46 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL SUBMUCOSAL TUMOUR:

# Drug Count
0 PANTOPRAZOLE 15
1 ASPIRIN 14
2 ASPIRIN 325 MG 14
3 ASPIRIN 81 MG 14
4 AMLODIPINE 9
5 METOPROLOL SUCCINATE 9
6 METOPROLOL SUCCINATE ER TABLETS 9
7 SIMVASTATIN 9
8 ESOMEPRAZOLE MAGNESIUM 8
9 METOPROLOL 8
See all common drugs associated with GASTROINTESTINAL SUBMUCOSAL TUMOUR

GASTROINTESTINAL SUBMUCOSAL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CROMOLYN SODIUM 6 0.0016
1 CETYLPYRIDINIUM CHLORIDE 1 0.0015
2 TERBINAFINE TABLETS 250 MG 1 0.0008
3 DAPRODUSTAT 1 0.0005
4 SILODOSIN 2 0.0005
5 ADO-TRASTUZUMAB EMTANSINE 4 0.0005
6 CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE 1 0.0004
7 GRANISETRON HYDROCHLORIDE 4 0.0004
8 GRANISETRON 4 0.0004
9 VALSARTAN AND HYDROCHLOROTHIAZIDE 5 0.0004
See all drugs enriched for association with GASTROINTESTINAL SUBMUCOSAL TUMOUR